BOSTON, Aug. 24, 2026 (GLOBE NEWSWIRE) -- Elicio Therapeutics, Inc. (Nasdaq: ELTX, “Elicio” or the “Company”), a clinical-stage biotechnology company developing next-generation immunotherapies for KRAS-driven cancers, today announced that management will participate in one-on-one meetings at the upcoming Wells Fargo 21 st Annual Healthcare Conference, taking place September 8-10, 2026, in Boston, MA.
Globe Newswire
Original source
wells fargo
Check live status on DownRightNow

